How to Get Rid of Premature Ventricular Contractions (PVCs)

Most PVCs can be reduced or eliminated through a combination of lifestyle changes, medication, or catheter ablation, depending on how frequent they are, how much they bother you, and whether they threaten heart function. If your PVC burden is low and your heart is structurally normal, simple reassurance and trigger avoidance may be all you need. When PVCs are frequent enough to cause symptoms or weaken the heart, beta-blockers, calcium channel blockers, antiarrhythmic drugs, and catheter ablation all have solid track records. The right approach depends on details that are worth understanding before you and your doctor choose a path.

When PVCs Actually Need Treatment

Not every PVC demands intervention. The threshold for treatment depends on two things: how you feel and what the extra beats are doing to your heart. People with mild or no symptoms, a low PVC burden, and normal heart function are often best served with reassurance alone, since PVCs are extremely common and usually harmless.¹ Treatment becomes important when PVCs cause bothersome palpitations, dizziness, or exercise intolerance, or when they occur frequently enough to damage the heart muscle over time.

The concept of “PVC burden” is central here. It refers to the percentage of all your heartbeats in a given period that are premature ventricular contractions. A burden above roughly 10% is where the risk of developing PVC-induced cardiomyopathy begins, though it varies between individuals. In one study, patients whose hearts had weakened from PVCs carried an average burden of about 33%, while those with preserved heart function averaged around 13%. A burden above 24% was the best cutoff for separating those two groups.² But even a burden as low as 10% has, in some cases, caused reversible cardiomyopathy, so there is no perfectly safe number.

If you have been told your PVCs are “benign” but they still make you miserable, that is a legitimate reason to pursue treatment. Quality of life counts. Either medication or catheter ablation is considered a reasonable first-line option, and patient preference plays a real role in which to try first.¹

Lifestyle Changes That Can Help

Before reaching for pills or procedures, modifying everyday triggers is the logical first step. Several lifestyle factors have been linked to increased PVC frequency and severity, including stress, poor sleep, alcohol, nicotine, and stimulant drugs.³ Of these, the ones most within your control are worth addressing first.

• Alcohol: Excessive drinking disrupts the heart’s electrical signaling. Even moderate consumption can provoke extra beats in susceptible people. Cutting back or eliminating alcohol is one of the simplest experiments you can run.
• Nicotine: Smoking and vaping both stimulate the sympathetic nervous system and destabilize cardiac rhythm. Quitting reduces PVC frequency for many people.
• Sleep: Insomnia and sleep deprivation throw off the autonomic nervous system, the branch of your nervous system that regulates heartbeat. Improving sleep hygiene can noticeably reduce PVC counts.
• Stress: Chronic stress keeps the body in a state of sympathetic overdrive. Techniques that lower overall arousal, from regular exercise to structured relaxation, tend to help.
• Stimulant drugs: Amphetamines, cocaine, and even some decongestants can precipitate PVCs through heightened cardiac stimulation.

These changes alone will not eliminate PVCs in everyone, but they often reduce the burden enough to relieve symptoms, especially when the burden is moderate. They also make medications and procedures work better if those become necessary.

The Caffeine Question

Caffeine is probably the trigger people ask about most. The conventional wisdom that coffee causes heart palpitations runs deep, and many PVC sufferers are told to cut it out entirely. The evidence, though, is more nuanced than the advice.

A comprehensive review found that caffeine can affect arrhythmia risk in a dose-dependent way, with heavy intake raising cardiovascular risk, particularly in people who drink large amounts during long work shifts.⁴ However, a study that directly measured ectopic beats across different levels of coffee, tea, and chocolate intake found no significant relationship. People who consumed more caffeinated products did not have more PVCs per hour than those who consumed less, even after adjusting for other risk factors.⁵

The practical takeaway: moderate caffeine intake is probably fine for most people with PVCs. If you notice a clear personal connection between your coffee and your palpitations, cutting back makes sense. But blanket caffeine elimination for all PVC patients is not strongly supported by the data. This is one of those areas where individual experience matters more than population-level averages.

Electrolytes and Magnesium

Electrolyte imbalances, particularly low magnesium and low potassium, can destabilize the electrical properties of heart cells and provoke PVCs. When magnesium drops, intracellular calcium and sodium rise while potassium falls, causing the cell membrane’s electrical potential to fluctuate and triggering abnormal beats.⁶

Correcting a genuine magnesium or potassium deficiency can reduce PVC frequency, and your doctor can check these with a simple blood test. But taking magnesium supplements when your levels are already normal is a different story, and the evidence for that is much weaker. If you are on a diuretic, sweat heavily, or have dietary gaps that might lower your magnesium, supplementation is more likely to help. The key point is to identify a deficiency before treating one.

Medications for PVC Suppression

When lifestyle changes are not enough, drugs are the next step. The two main first-line categories are beta-blockers and non-dihydropyridine calcium channel blockers (such as verapamil and diltiazem). Both work by dampening the electrical excitability of the heart, though they do so through different mechanisms.

Beta-blockers work best in people whose PVCs increase when the heart rate goes up. In one study, about a third of patients achieved at least a 50% reduction in daily PVC burden on beta-blockers. The strongest predictor of a good response was having PVCs that tracked with heart rate: when PVCs fired more often at faster heart rates, beta-blockers were roughly three times more likely to work.⁷ For PVCs that do not follow this pattern, calcium channel blockers may be more appropriate. A study comparing the two found that each class had a distinct responder profile, with some PVC characteristics favoring one over the other.⁸

If these first-line drugs fail, stronger antiarrhythmic drugs like flecainide, propafenone, and sotalol become options. These are more potent PVC suppressors but carry additional risks, especially in people with underlying heart disease. In patients with idiopathic PVCs (meaning no structural heart disease), a comparison of flecainide, propafenone, and sotalol found that serious side effects were rare, with no cases of sudden cardiac death or proarrhythmic events.⁹ Class IC drugs like flecainide have a complicated reputation because they increased death rates in a landmark trial decades ago involving patients who had had heart attacks. But in carefully selected patients with PVC-induced cardiomyopathy and no ischemic heart disease, class IC drugs reduced PVC burden substantially and improved heart function without sudden deaths over an average follow-up of nearly four years.¹⁰ They have also shown benefit in patients with non-ischemic cardiomyopathy who already had implantable defibrillators, with PVC burden dropping significantly and heart function improving.¹¹

The bottom line on drugs: they suppress PVCs and can relieve symptoms and protect heart function, but the right choice depends on the characteristics of your PVCs, your heart’s structure and function, and the risk profile of each drug. This is emphatically not a self-medication situation.

Catheter Ablation

Catheter ablation is the most effective way to eliminate PVCs entirely. A catheter is threaded through a blood vessel to the spot in the heart where the extra beats originate, and that tiny area of tissue is destroyed with heat or cold. Success rates are high, especially when the PVC comes from the right ventricular outflow tract, which is the most common origin. In a large safety analysis, the overall acute success rate was about 94%, with the highest success rates for right ventricular outflow tract PVCs at 97%.¹²

Not all PVCs are equally easy to ablate. Those arising from the outside surface of the heart or deep within the wall between the ventricles are trickier. Intramural outflow tract PVCs, for instance, achieved acute suppression in about 75% of cases in a multicenter study, and many patients required specialized techniques or repeat procedures.¹³ The origin of the PVC matters a great deal for predicting outcomes, and your electrophysiologist will map the location before deciding on a strategy.

For people whose PVCs have already weakened their heart, ablation can reverse the damage. In one study, heart function normalized at an average of about five months after a successful procedure, and roughly two-thirds of patients recovered within four months. For the remaining third, recovery took longer but still occurred in most cases.¹⁴ A multicenter prospective study confirmed that heart function improved substantially after successful ablation regardless of whether the patient had preexisting heart disease.¹⁵ Cardiac MRI after ablation showed that about 79% of patients recovered normal function.¹⁶

Ruling Out Hidden Heart Disease

Before settling on a treatment, your doctor will want to make sure your PVCs are not a symptom of something more serious. The initial evaluation typically includes an echocardiogram to check heart structure and function, and a Holter monitor or longer-duration patch monitor to quantify the burden. Measuring burden over just 24 hours can be misleading, since PVC frequency fluctuates day to day. One large analysis found that the average error in estimating burden dropped from about 3% with a single day of monitoring to under 1% with ten days.¹⁷

Cardiac MRI plays an increasingly important role, especially when PVCs are frequent and the echocardiogram looks normal. MRI can detect subtle tissue abnormalities invisible on ultrasound. In one study, about one in seven patients with frequent PVCs and no known heart disease had a myocardial abnormality found only on MRI, and those findings predicted worse outcomes.¹⁸ This matters because the label “idiopathic PVCs” is reassuring only if you have genuinely excluded underlying disease. MRI is the best tool for doing that.¹⁹

Supplements and Alternative Approaches

Given how common PVCs are, it is no surprise that people look for over-the-counter remedies. The most studied supplement for arrhythmias is omega-3 fatty acids (fish oil). The results, frustratingly, are mixed. A randomized trial in adults with frequent PVCs found that 1.5 grams per day of fish oil did not significantly reduce PVC counts compared to placebo.²⁰ However, a study in children with frequent idiopathic PVCs reported a 45% reduction in PVC burden with omega-3 supplementation, possibly through improved autonomic function.²¹ The age difference, the population studied, and the small sizes of both trials make it hard to draw a firm conclusion.

Coenzyme Q10 and carnitine have been proposed as potential antiarrhythmic supplements, but clinical evidence remains limited and insufficient to recommend routine use. Some herbal supplements marketed for heart rhythm can actually cause arrhythmias or interact dangerously with prescription medications like blood thinners.²² If you are considering any supplement, discuss it with your cardiologist, especially if you are on other medications.

A newer and intriguing approach is transcutaneous vagus nerve stimulation. In a randomized crossover trial of patients whose PVCs had not responded to medication, low-level electrical stimulation delivered to the ear (targeting the vagus nerve) reduced PVC burden by about 13% compared with sham stimulation.²³ This is still experimental and not widely available, but it suggests that modulating the autonomic nervous system directly could become a real therapeutic option.

PVCs During Exercise and What They Mean

Many people notice PVCs during or after exercise and wonder whether they should be worried. The timing matters more than you might expect. PVCs that appear during exercise itself have generally not been associated with increased mortality risk in large studies.²⁴ PVCs that appear during the recovery phase after exercise, however, have been linked to higher cardiovascular mortality.²⁵

But even recovery PVCs carry different implications depending on the context. A study that combined exercise testing with echocardiography found that PVCs during recovery were associated with increased cardiovascular death only when echocardiographic abnormalities were also present. People with recovery PVCs and a structurally normal heart on echo did not face increased risk compared to people with no PVCs at all.²⁶ The lesson: exercise PVCs deserve mention to your doctor, especially if they show up during recovery, but they are rarely dangerous on their own in a structurally normal heart.

PVCs in Athletes and During Pregnancy

Athletes pick up PVCs frequently on screening ECGs, particularly when exercise testing is included. In most cases, no underlying heart disease is present, and the athlete can be cleared for competition with periodic follow-up. The Italian Society of Sports Cardiology recommends a stepwise evaluation that looks at where the PVC originates on the ECG, how it behaves during exercise, and whether the echocardiogram is normal. When all these checks come back clean, the athlete can generally be reassured.²⁷ The red flags are PVCs with multiple different shapes, PVCs that get worse with exercise, and any hint of structural abnormality on imaging.

Pregnancy raises its own questions. PVCs tend to increase during pregnancy due to the expanded blood volume and hormonal shifts. For women with structurally normal hearts, the overall outcomes for both mother and baby have been reassuring. One study found that maternal and neonatal outcomes in women with frequent PVCs were similar to controls, though a higher rate of placental abruption was observed in those with the highest burdens.²⁸ Another study found that about 11% of pregnancies in women with high PVC burden were complicated by a maternal cardiac event (heart failure or sustained arrhythmia requiring treatment), and all events occurred in women with a burden above 5%. All were successfully managed with medication.²⁹ For women planning pregnancy who already have a high PVC burden, treatment before conception, including ablation, is worth discussing.

The Hiatal Hernia Connection

One underappreciated trigger for PVCs is gastrointestinal. A hiatal hernia, where the upper stomach pushes through the diaphragm into the chest, can mechanically and neurally irritate the heart and provoke arrhythmias. Case reports describe patients with high PVC burdens whose arrhythmias resolved completely after surgical repair of a hiatal hernia.³⁰ In one such case, PVCs in a bigeminy pattern (every other beat) disappeared after hernia repair and did not recur on follow-up monitoring.³¹

This is not common, and it is easy to overstate its importance. But if your PVCs consistently worsen after eating, when lying flat, or in the presence of acid reflux symptoms, it is worth raising with your doctor. Gastrocardiac syndrome is one of those diagnoses that gets missed precisely because cardiologists are not thinking about the stomach and gastroenterologists are not thinking about the heart.

Using Wearables to Track PVCs

Consumer wearable devices like the Apple Watch can now record single-lead ECGs, and research is starting to explore how useful these recordings are for PVC management. A study found that the polarity of PVC signals captured by an Apple Watch matched standard clinical ECGs in most cases and could help identify the origin of the PVCs, which in turn informs treatment decisions.³² Meanwhile, analysis of brief wearable-format ECG recordings has shown that detecting PVCs even in a 15-second strip is associated with long-term cardiovascular risk, particularly heart failure.³³

Wearables are not a substitute for medical-grade monitoring. A 15-second snapshot cannot quantify daily burden the way a multi-day patch monitor can. But they can serve as a useful early signal. If your smartwatch flags frequent PVCs, bring the recordings to your appointment. They give your cardiologist something concrete to evaluate and can speed up the decision to order formal monitoring.